Manufacturer record

Bharat Parenterals Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

17 batches manufactured by Bharat Parenterals Ltd (Gujarat) were declared Not of Standard Quality between May 2019 and December 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

17 records linked to Bharat Parenterals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
17Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, May 2019 to Dec 2024

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

17
NSQ batches since 2019
14
Products affected
Assay
Most common failure
Dec 2024
Latest alert

Flagged batches per year

2019 · 22020 · 32021 · 52022 · 42023 · 12024 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Cefpodoxime Tablets IP 200 mg (Jan Aushadhi) CT3096Mfg 2023-09 · Exp 2025-08 Assay of CefpodoximeAssay CFDL Jammu (J&K)State lab Dec 2024
Sodium Fusidate Cream 2 % 344Mfg 2023-11 · Exp 2025-10 AssayAssay CDTL MumbaiCDSCO lab Oct 2024
Meropenem Injection IP 0.5 g PI3075Mfg 2023-04 · Exp 2025-03 Bacterial Endotoxin TestBacterial endotoxins CDL KolkataCDSCO lab Nov 2023
Sodium Valproate Tablets I.P. 200 mg T2282Mfg 2022-08 · Exp 2024-07 Related SubstancesRelated substances CDL KolkataCDSCO lab Dec 2022
Sodium Valproate Tablets I.P. 200 mg T2283Mfg 2022-08 · Exp 2024-07 Related SubstancesRelated substances CDL KolkataCDSCO lab Dec 2022
Sodium Valproate Tablets IP 500 mg T2240Mfg 2022-07 · Exp 2024-06 Related SubstancesRelated substances CDL KolkataCDSCO lab Nov 2022
Amikacin Injection IP 100 mg / 2 ml- 2 ml P1317Mfg 2021-05 · Exp 2023-04 Description & Particulate MatterDescription CDL KolkataCDSCO lab Mar 2022
Phytomenadione Injectoin IP 10mg/ml (Vitamin K1 Injection) 1 ml P0383Mfg 2020-07 · Exp 2022-06 Description, Particulate Matter and SterilityDescription CDL KolkataCDSCO lab Nov 2021
Phenytoin Sodium Injection 50mg / ml P0492Mfg 2020-09 · Exp 2022-08 pH & VolumepH CDL KolkataCDSCO lab Aug 2021
Quinine Sulphate Tablets I.P. 300 mg T8296Mfg 2018-10 · Exp 2021-09 DissolutionDissolution RDTL GuwahatiState lab Jul 2021
Folic Acid Tablets IP T9122Mfg 2019-05 · Exp 2022-04 AssayAssay RDTL GuwahatiCDSCO lab Jun 2021
OLANZAPINE Tablets I.P. 5 mg T0434Mfg 2020-08 · Exp 2023-07 DissolutionDissolution CDL KolkataCDSCO lab Apr 2021
Rosuvastain Tablets IP 20 mg T9329Mfg 2019-09 · Exp 2022-08 DissolutionDissolution CDTL MumbaiCDSCO lab Dec 2020
Pantoprazole Tablets IP 40 mg T9356Mfg 2019-09 · Exp 2022-08 DissolutionDissolution CDTL MumbaiCDSCO lab Dec 2020
Folic Acid Tablets I.P. 5mg. T9125Mfg 2019-05 · Exp 2022-04 ASSAYAssay RDTL GuwahatiState lab Aug 2020
Clopidogrel & Aspirin Tablets T8202Mfg 2018-07 · Exp 2020-06 Free Salicylic Acid TestOther CDL KolkataCDSCO lab Aug 2019
MARIAGO (Methylergometrine Maleate Injection I.P.) P7274Mfg 2017-06 · Exp 2019-05 AssayAssay CDL KolkataCDSCO lab May 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.